In addition to TPA, we characterized the effects of another small molecule drug, verteporfin (VP), a benzoporphyrin derivative, which has been reported to inhibit cell growth in cancer cells through down-regulating CYR61 expression [37, 38]. The gene discussed is CCN1; the disease is cancer.